Last updated on September 2018

Study of A-101 Topical Solution for the Treatment of Common Warts


Brief description of study

A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

Detailed Study Description

A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

Clinical Study Identifier: NCT03687372

Contact Investigators or Research Sites near you

Start Over

Judy Schnyder

Aclaris Investigational Site
Verona, NJ United States
0.41miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.